A nurse is assessing a client who takes prescribed daily aspirin. Which of the following findings indicates salicylism?

An ST-elevation myocardial infarction(STEMI) occurs when a coronary artery is completely occluded, leading to transmural myocardial ischemiaand necrosis. This medical emergency is identified by specific ECG changes and elevated cardiac biomarkerslike Troponin I (> 0.03 ng/mL). Immediate pharmacologic intervention focuses on reperfusion, preventing further thrombus propagation, and reducing myocardial oxygen demand to preserve functional cardiac tissue.

Rationale:

A. Heparin is an anticoagulant indicated in the acute phase of a STEMI to prevent the formation and extension of fibrin clots. By accelerating the action of antithrombin 3, it neutralizes thrombin and factor Xa. This prevents further occlusion of the coronary artery while the patient awaits definitive reperfusion therapy like percutaneous coronary intervention.

B. Digoxin is a positive inotrope and negative chronotrope primarily used for chronic heart failure or atrial fibrillation with rapid ventricular response. In the setting of an acute STEMI, it is generally avoided because it increases myocardial oxygen consumptionby increasing contractility. Excessive oxygen demand during an active infarction can exacerbate myocardial injury and extend the area of necrosis.

C. Aspirin is a cornerstone of acute coronary syndrome management due to its immediate antiplatelet effects. It irreversibly inhibits cyclooxygenase-1, preventing the synthesis of thromboxane A2, which is a potent stimulator of platelet aggregation. Administering aspirin early significantly reduces mortality by limiting the size of the developing thrombus within the obstructed coronary vessel.

D. Morphine is the preferred analgesic for managing the crushing chest pain associated with myocardial infarction when nitrates are insufficient. Beyond pain relief, it provides beneficial hemodynamic effectsby reducing preload through venous dilation and decreasing systemic vascular resistance. These actions lower the myocardial workload and oxygen demand, while also alleviating the patient's anxiety and sympathetic surge.

E. Dopamine is a sympathomimetic amine used for hemodynamic support in cases of cardiogenic shock or clinically significant hypotension. The client's blood pressure is currently stable at 126/80 mm Hg, making a vasopressor or potent inotrope unnecessary and potentially harmful. Administering dopamine in a stable STEMI patient would unnecessarily increase heart rate and myocardial metabolic demand, worsening the ischemia.

A medication error is an adverse eventthat necessitates immediate clinical and administrative action to ensure patient safety. The primary goal following an error is to assess the client for physiological instabilityand implement corrective treatments. Transparent communicationwith the healthcare team is essential for mitigating harm and documenting the event for future quality improvement initiatives.

Rationale:

A.The nursing supervisor should be notified as part of the facility's internal administrative process, but this is not the most immediate priority. While the supervisor oversees the unit's safety protocols, they cannot provide the medical orders necessary to treat a potential adverse reaction. Administrative notification should follow the clinical notification of the primary healthcare provider to ensure the patient's immediate health.

B.Agency administration is typically notified through the formal filing of an incident report once the patient is stable and immediate care has been coordinated. The administration uses this data for risk management and system-wide improvements rather than direct clinical intervention. Therefore, reporting to this department first would inappropriately delay the necessary medical assessment of the affected client.

C.The client's provider must be notified first so they can evaluate the clinical impact of the error and prescribe any necessary antidotes or monitoring. Immediate medical assessment is the highest priority to ensure the patient does not suffer from toxic effects or therapeutic failure. The provider is responsible for determining the next steps in the client's medical management plan.